Press Releases
Ascend continues broad expansion into new markets, launches HiDura™ MED portfolio
Ascend Performance Materials announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura™ brand.
HiDura MED products meet ISO 10993-5 and 10993-10 testing criteria and can be used in a...
Press Releases
Vetter drives its sustainability campaign forward
Vetter, a globally leading contract development and manufacturing organization (CDMO), has in place a comprehensive sustainability strategy that has made it a pioneer in this energy-intensive industry. The family-owned company is undertaking numerous initiatives aimed at making sustainability manifest...
Press Releases
Pharmaceutical Packaging Market Extensive Growth Opportunities To Be Witnessed By 2019-2029
According to the report compiled by Fact.MR, the pharmaceutical packaging market is expected to witness steady growth. The market is projected to increase to 7.5% CAGR during the forecast period 2019-2029.
Increasing healthcare spending in developed countries and growing preference for convenient...
Press Releases
Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).
In...
Press Releases
Samsung Biologics introduces new development platforms S-DUAL and DEVELOPIC at BPI Boston 2022
Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year's BioProcess International Conference and Exhibition in Boston.
S-DUAL™ is a high-yield bispecific antibody platform...
Press Releases
Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program
Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, announced an update on the development of Oxilio’s OXL001 product.
Oxilio is pleased to announce...
Press Releases
Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research
Velocity Clinical Research (“Velocity”), the leading integrated research site organization with 40 locations across 19 U.S. states and Europe, announces the findings of its U.S. patient survey, which aimed to better understand patient preference for study decentralization activities in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















